FULGENT GENETICS, INC. Intangible Assets, Net (Excluding Goodwill)
FULGENT GENETICS, INC. (FLGT) had Intangible Assets, Net (Excluding Goodwill) of $149.26 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2026-07-30
- 2026-06-30: Intangible Assets, Net (Excluding Goodwill) $149.26M.
- 2026-03-31: Intangible Assets, Net (Excluding Goodwill) $153.99M.
- 2025-12-31: Intangible Assets, Net (Excluding Goodwill) $133.28M.
- 2025-09-30: Intangible Assets, Net (Excluding Goodwill) $135.25M.
| Period end | Intangible Assets, Net (Excluding Goodwill) | Intangible Assets, Net (Excluding Goodwill) as first filed |
|---|---|---|
| 2026-06-30 | $149.26M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $153.99M 10-Q · filed 2026-05-01 | |
| 2025-12-31 | $133.28M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $135.25M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $135.25M 10-Q · filed 2025-11-07 | $131.06M 10-Q · filed 2025-08-01 |
| 2025-03-31 | $133.01M 10-Q · filed 2025-05-02 | |
| 2024-12-31 | $134.98M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $137.12M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $138.97M 10-Q · filed 2024-08-02 | |
| 2024-03-31 | $140.99M 10-Q · filed 2024-05-03 | |
| 2023-12-31 | $143.05M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $144.49M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $146.47M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $148.70M 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $150.64M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $87.85M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $89.69M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $35.04M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $35.91M 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |